We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Venture Life Group Plc | LSE:VLG | London | Ordinary Share | GB00BFPM8908 | ORD 0.3P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.75 | 1.96% | 39.00 | 38.00 | 39.50 | 40.25 | 38.75 | 39.00 | 299,065 | 16:35:01 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Misc Retail Stores, Nec | 43.98M | 520k | 0.0041 | 94.51 | 48.76M |
From Apr 2019 to Apr 2024
TIDMVLG
RNS Number : 2296V
Venture Life Group PLC
20 July 2018
20 July 2018
Venture Life Group plc
(the "VLG or the "Company")
Appointment of Joint Broker
Venture Life Group plc (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the self-care market is pleased to announce the appointment, with immediate effect, of Cenkos Securities plc as joint broker, alongside its existing nominated adviser and joint broker Northland Capital Partners Limited and Turner Pope Investments Limited.
Contacts
Venture Life Group PLC +44 (0) 1344 742870 Jerry Randall, Chief Executive Officer Adrian Crockett, Chief Financial Officer Northland Capital Partners Limited (Nominated Adviser and Joint Broker) +44 (0) 20 3861 6625 Matthew Johnson / Edward Hutton (Corporate Finance) Vadim Alexandre (Corporate Broking) Cenkos Securities PLC (Joint Broker) +44 (0) 20 7397 8900 Camilla Hume / Mark Connelly (Corporate Finance) Michael F Johnson / Russell Kerr (Sales) Turner Pope Investments (TPI) Ltd (Joint Broker) +44 (0) 20 3621 4120 James Pope / Ben Turner Walbrook PR + 44 (0) 20 7933 8780 Anna Dunphy venturelife@walbrookpr.com +44 (0) 7876 741 001
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group's product portfolio includes some key products such as the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, medical devices for women's intimate healthcare and haemorrhoids and dermo-cosmetics for addressing the signs of ageing.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.
Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCVKLFFVDFEBBZ
(END) Dow Jones Newswires
July 20, 2018 02:00 ET (06:00 GMT)
1 Year Venture Life Chart |
1 Month Venture Life Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
